Article

Population Vaccine Effectiveness and its Implication for Control of the Spread of COVID-19 in the US

2021-05-05

Abstract excerpt

Realized vaccine efficacy in population is highly different from the individual vaccine efficacy measured in clinical trial. The realized vaccine efficacy in population is substantially affected by the vaccine age-stratified prioritization strategy, population age-structure, non-pharmaceutical intervention (NPI). We proposed a population vaccine efficacy which integrated individual vaccine efficacy, vaccine priori...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3febb8d4-66ce-501f-a0ad-a071a91530df
DOI: 10.1101/2021.04.30.21256228

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Population Vaccine Effectiveness and its Implication for Control of the Spread of COVID-19 in the USDOI 10.1101/2021.04.30.21256228Read

COVID-19 deaths and hospitalizations averted by rapid vaccination rollout in the United StatesSemantic proximity Read

Effectiveness of Covid-19 Vaccines in the United States Over 9 Months: Surveillance Data from the State of North CarolinaSemantic proximity Read

Real-world effectiveness and non-inferiority evaluation and comparison of mRNA- and protein-based COVID-19 vaccines: a randomized study protocol (BEEHIVE)Semantic proximity Read

Impact of SARS-CoV-2 Vaccines on Covid-19 Incidence and Mortality in the United StatesSemantic proximity Read

Analysis of the Potential Efficacy and Timing of COVID-19 Vaccine on Morbidity and MortalitySemantic proximity Read

A New Vaccination Assessment Method and Strategy for COVID-19Semantic proximity Read

Critical assessment of the impact of vaccines and waning/boosting of immunity on the burden of COVID-19 in the U.SSemantic proximity Read

Surveillance of COVID-19 in a Vaccinated Population: A Rapid Literature ReviewSemantic proximity Read

COVID-19 Case Numbers as a Function of Regional Testing Strategy, Vaccination Coverage, and Vaccine TypeSemantic proximity Read

Effectiveness of the 2023–2024 Omicron XBB.1.5-containing mRNA COVID-19 Vaccine (mRNA-1273.815) in Preventing COVID-19–related Hospitalizations and Medical Encounters Among Adults in the United StatesSemantic proximity Read

COVID-19 Endemic Plan: Impact of Vaccination and Non-pharmaceutical Interventions with Viral Variants and Waning Immunity Using an Agent-Based SimulationSemantic proximity Read

Personalized-Dose COVID-19 Vaccination in a Wave of Virus Variants of Concern: Trading Individual Efficacy for Societal BenefitSemantic proximity Read